Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Factors associated with pneumococcal vaccination uptake by cancer survivors.

Tytuł :
Factors associated with pneumococcal vaccination uptake by cancer survivors.
Autorzy :
Song YM; Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea. .
Shin J; Department of Family Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.
Ko H; Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Yoo JE; Department of Family Medicine & Health Promotion Center, Seoul National University Hospital, Seoul, South Korea.
Cho IY; Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shin DW; Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
Cho B; Department of Family Medicine & Health Promotion Center, Seoul National University Hospital, Seoul, South Korea.
Lee JE; Department of Family Medicine, CHA Bundang Medical Center, CHA University, Seongnam-si, South Korea.
Hwang J; Department of Physical and Rehabilitation Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee J; Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.
Pokaż więcej
Źródło :
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2021 Apr; Vol. 15 (2), pp. 234-243. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article
Język :
English
Imprint Name(s) :
Original Publication: New York, N.Y. : Springer Science + Business Media, c2007-
References :
Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Dizon D, et al. Survivorship: immunizations and prevention of infections, version 2.2014. J Natl Compr Cancer Netw. 2014;12:1098–111. (PMID: 10.6004/jnccn.2014.0107)
Semenov YR, Starmer HM, Gourin CG. The effect of pneumonia on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope. 2012;122:1994–2004. (PMID: 10.1002/lary.23446)
Yen TT, Lin CH, Jiang RS, Shih YT, Yen HR, Liang KL. Incidence of late-onset pneumonia in patients after treatment with radiotherapy for nasopharyngeal carcinoma: a nationwide population-based study. Head Neck. 2015;37:1756–61. (PMID: 10.1002/hed.23827)
Lee JO, Kim DY, Lim JH, Seo MD, Yi HG, Kim YJ, et al. Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients. Lung Cancer. 2008;62:381–4. (PMID: 10.1016/j.lungcan.2008.03.015)
Dyer G, Gilroy N, Brice L, Kabir M, Gottlieb D, Huang G, et al. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia. Transpl Infect Dis. 2019;21:e13043. (PMID: 10.1111/tid.13043)
Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822–5. (PMID: 252332845779453)
Chiou WY, Hung SK, Lai CL, Lin HY, Su YC, Chen YC, et al. Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization: a nationwide population-based cohort study. Medicine (Baltimore). 2015;94:e1022. (PMID: 10.1097/MD.0000000000001022)
Chiou WY, Lee MS, Hung SK, Lin HY, Lo YC, Hsu FC, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study. BMJ Open. 2018;8:e019364. (PMID: 10.1136/bmjopen-2017-019364)
Lowenstein LM, Ouellet JA, Dale W, Fan L, Gupta MS. Preventive care in older cancer survivors. J Geriatr Oncol. 2015;6:85–92. (PMID: 10.1016/j.jgo.2014.12.003)
Fairley TL, Hawk H, Pierre S. Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: data use for comprehensive cancer control. Prev Chronic Dis. 2010;7:A09. (PMID: 20040224)
Li J, Thompson TD, Richards TB, Steele CB. Racial and ethnic differences in health behaviors and preventive health services among prostate cancer survivors in the United States. Prev Chronic Dis. 2016;13:E95. (PMID: 274429954956476)
Underwood JM, Townsend JS, Stewart SL, Buchannan N, Ekwueme DU, Hawkins NA, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors--behavioral risk factor surveillance system, United States, 2009. MMWR Surveill Summ. 2012;61:1–23. (PMID: 22258477)
Moran RJ, Waalen J, Murphy J, Nalawade V, Schiaffino M. Pneumococcal vaccination utilization among Hispanic long-term colorectal cancer survivors: cross-sectional assessment of claims. JMIR Public Health Surveill. 2019;5:e12603. (PMID: 10.2196/12603)
Malosh R, Ohmit SE, Petrie JG, Thompson MG, Aiello AE, Monto AS. Factors associated with influenza vaccine receipt in community dwelling adults and their children. Vaccine. 2014;32:1841–7. (PMID: 10.1016/j.vaccine.2014.01.075)
Mo PK, Lau JT. Influenza vaccination uptake and associated factors among elderly population in Hong Kong: the application of the health belief model. Health Educ Res. 2015;30:706–18. (PMID: 10.1093/her/cyv038)
Dyda A, MacIntyre CR, McIntyre P, Newall AT, Banks E, Kaldor J, et al. Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine. 2015;33:3299–305. (PMID: 10.1016/j.vaccine.2015.05.046)
Lv M, Fang R, Wu J, Pang X, Deng Y, Lei T, et al. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors. Vaccine. 2016;34:2135–40. (PMID: 10.1016/j.vaccine.2016.02.032)
Palmer NR, Geiger AM, Felder TM, Lu L, Case LD, Weaver KE. Racial/ethnic disparities in health care receipt among male cancer survivors. Am J Public Health. 2013;103:1306–13. (PMID: 10.2105/AJPH.2012.301096)
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70. (PMID: 10.1111/j.1600-0447.1983.tb09716.x)
Oh SM, Min K-J, Park D-B. A study on the standardization of the hospital anxiety and depression scale for Koreans — a comparison of normal, depressed and anxious groups. J Korean Neuropsychiatr Assoc. 1999;38:289–96.
Cassidy W, Marioneaux DM, Windham AF, Manning S, Fishbein D, Horswell RL. Factors influencing acceptance of influenza vaccination given in an ED. Am J Emerg Med. 2009;27:1027–33. (PMID: 10.1016/j.ajem.2008.05.014)
Choe YJ, Yang JJ, Park SK, Choi EH, Lee HJ. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. J Korean Med Sci. 2013;28:1283–8. (PMID: 10.3346/jkms.2013.28.9.1283)
Lee JK, Choi WS. Immunization policy in Kore. Infect Chemother. 2008;40:14–23. (PMID: 10.3947/ic.2008.40.1.14)
Yun HS, Min YW, Chang DK, Rhee PL, Kim JJ, Rhee JC, et al. Factors associated with vaccination among inflammatory bowel disease patients in Korea. Korean J Gastroenterol. 2013;61:203–8. (PMID: 10.4166/kjg.2013.61.4.203)
Kang J, Song YM. Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination. Vaccine. 2016;34:6181–6. (PMID: 10.1016/j.vaccine.2016.10.076)
Chen CH, Chiu PJ, Chih YC, Yeh GL. Determinants of influenza vaccination among young Taiwanese children. Vaccine. 2015;33:1993–8. (PMID: 10.1016/j.vaccine.2015.01.032)
Kee SY, Lee JS, Cheong HJ, Chun BC, Song JY, Choi WS, et al. Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Inf Secur. 2007;55:273–81.
Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007;26:136–45. (PMID: 10.1037/0278-6133.26.2.136)
Denlinger CS, Sanft T, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, et al. Survivorship, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16:1216–47. (PMID: 10.6004/jnccn.2018.0078)
Heo J, Chun M, Oh YT, Noh OK, Kim L. Influenza among breast cancer survivors in South Korea: a nationwide population-based study. In Vivo. 2017;31:967–72. (PMID: 288829675656874)
Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, et al. Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol. 2002;19:71–8. (PMID: 10.1385/MO:19:2:71)
Shah GL, Shune L, Purtill D, Devlin S, Lauer E, Lubin M, et al. Robust vaccine responses in adult and pediatric cord blood transplantation recipients treated for hematologic malignancies. Biol Blood Marrow Transplant. 2015;21:2160–6. (PMID: 10.1016/j.bbmt.2015.08.010)
Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Carducci MA, et al. Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv. 2011;5:283–91. (PMID: 10.1007/s11764-011-0181-y)
Oh MG, Han MA, Yun NR, Park J, Ryu SY, Kim DM, et al. A population-based, nationwide cross-sectional study on influenza vaccination status among cancer survivors in Korea. Int J Environ Res Public Health. 2015;12:10133–49. (PMID: 10.3390/ijerph120810133)
Choi KH, Park SM, Lee K, Lee JH, Park JS. Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the fourth & fifth Korea National Health and nutrition examination surveys. J Korean Med Sci. 2014;29:1061–8. (PMID: 10.3346/jkms.2014.29.8.1061)
Grant Information :
1720270 Ministry of Health and Welfare
Contributed Indexing :
Keywords: Cancer survivors; Exercise; Pneumococcal infections; Prevention; Vaccination
Entry Date(s) :
Date Created: 20200812 Latest Revision: 20210317
Update Code :
20210623
DOI :
10.1007/s11764-020-00927-2
PMID :
32779103
Czasopismo naukowe
Purpose: This study aimed to evaluate factors associated with pneumococcal vaccination uptake (PVU) of cancer survivors.
Methods: A total of 2032 Korean adult cancer survivors diagnosed between June of 1975 and February of 2018 have participated. Information on PVU status and selected variables were collected through self-administered questionnaires and medical record review. Factors associated PVU were investigated using multiple logistic regression analysis.
Results: PVU rate markedly differed by age strata and cancer sites: 73.9% for elderly (≥ 65 years) survivors and 34.6% for younger (< 65 years) survivors and 73.4% for lung cancer survivors and 42.1% for non-lung cancer survivors. Regular physical exercise was associated with higher PVU in both age groups: Odds ratio (OR) and 95% confidence interval (CI) were 1.52 (1.20, 1.94) for younger and 1.78 (1.09, 2.90) for elderly survivors. Complementary medication use was positively associated with PVU with borderline significance in both age groups. However, the association of PVU with other factors differed between the two age groups. In younger survivors, a positive association with PVU was evident for longer time lapse after cancer diagnosis, chronic disease, and living with spouse/or partner, while cancer stage, educational achievement, and alcohol use were inversely associated PVU. On the other hand, multi-modality (≥ 3) cancer treatment was inversely associated with PVU only in elderly survivors.
Conclusions: PVU of Korean cancer survivors was suboptimal in younger survivors and non-lung cancer survivors. Factors associated with PVU differed between younger and elderly survivors, and more diverse factors were identified for younger survivors.
Implications for Cancer Survivors: In order to promote adherence to PVU in cancer survivors, careful consideration of high-risk factors for non-immunization within cancer survivorship context would be necessary together with free-of-charge vaccination policy.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies